GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » C4X Discovery Holdings PLC (FRA:C4J) » Definitions » PB Ratio

C4X Discovery Holdings (FRA:C4J) PB Ratio : 1.02 (As of May. 29, 2024)


View and export this data going back to 2020. Start your Free Trial

What is C4X Discovery Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-29), C4X Discovery Holdings's share price is €0.116. C4X Discovery Holdings's Book Value per Share for the quarter that ended in Jan. 2024 was €0.11. Hence, C4X Discovery Holdings's PB Ratio of today is 1.02.

The historical rank and industry rank for C4X Discovery Holdings's PB Ratio or its related term are showing as below:

FRA:C4J' s PB Ratio Range Over the Past 10 Years
Min: 0.52   Med: 3.73   Max: 8.86
Current: 0.96

During the past 12 years, C4X Discovery Holdings's highest PB Ratio was 8.86. The lowest was 0.52. And the median was 3.73.

FRA:C4J's PB Ratio is ranked better than
82.8% of 1308 companies
in the Biotechnology industry
Industry Median: 2.53 vs FRA:C4J: 0.96

During the past 12 months, C4X Discovery Holdings's average Book Value Per Share Growth Rate was 81.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -27.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -28.50% per year.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of C4X Discovery Holdings was 248.50% per year. The lowest was -29.20% per year. And the median was -21.10% per year.

Back to Basics: PB Ratio


C4X Discovery Holdings PB Ratio Historical Data

The historical data trend for C4X Discovery Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C4X Discovery Holdings PB Ratio Chart

C4X Discovery Holdings Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 3.54 4.98 7.13

C4X Discovery Holdings Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.39 4.98 2.84 7.13 1.18

Competitive Comparison of C4X Discovery Holdings's PB Ratio

For the Biotechnology subindustry, C4X Discovery Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C4X Discovery Holdings's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, C4X Discovery Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where C4X Discovery Holdings's PB Ratio falls into.



C4X Discovery Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

C4X Discovery Holdings's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jan. 2024)
=0.116/0.114
=1.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


C4X Discovery Holdings  (FRA:C4J) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


C4X Discovery Holdings PB Ratio Related Terms

Thank you for viewing the detailed overview of C4X Discovery Holdings's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


C4X Discovery Holdings (FRA:C4J) Business Description

Traded in Other Exchanges
Address
53 Portland Street, Manchester One, Manchester, GBR, M1 3LD
C4X Discovery Holdings PLC is a drug discovery and development company. It has various proprietary and synergistic software platforms Taxonomy3, Conformetrix, and 4Sight. Taxonomy3 is a novel in silico platform technology that utilizes proprietary ground-breaking mathematical algorithms to perform complex multivariate analysis of genetic data. Conformetrix enables rational, accelerated 4D structural drug design using experimental data rather than theoretical data. The 4Sight allows its research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules.

C4X Discovery Holdings (FRA:C4J) Headlines

No Headlines